ALS - Public Comps and Valuation Multiples

ALS Overview

About ALS

Founded in the 1880s and listing on the ASX in 1952, ALS operates two divisions: commodities and life sciences. ALS commodities traditionally generated the majority of underlying earnings, providing geochemistry, metallurgy, inspection and mine site services for the global mining industry. Expansion into environmental, pharmaceutical and food testing areas has lessened earnings exposure to commodities.

Founded

1910

HQ

Employees

20.5K+

Website

alsglobal.com

Sectors

Laboratory Services

Financials

LTM Revenue $2.1B

LTM EBITDA $518M

EV

$8.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

ALS Financials

As of November 2025, ALS reported last 12-month revenue of $2.1B and EBITDA of $518M.

In the same period, ALS achieved $231M in LTM net income.

See ALS valuation multiples based on analyst estimates

ALS P&L

In the most recent fiscal year, ALS reported revenue of $2.0B and EBITDA of $444M.

ALS expects next 12-month revenue of XXX and NTM EBITDA of XXX

See ALS valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$2.1B	XXX	$2.0B	XXX	XXX	XXX
Gross Profit	n/a	XXX	$1.8B	XXX	XXX	XXX
Gross Margin	n/a	XXX	90%	XXX	XXX	XXX
EBITDA	$518M	XXX	$444M	XXX	XXX	XXX
EBITDA Margin	24%	XXX	23%	XXX	XXX	XXX
EBIT	$370M	XXX	$279M	XXX	XXX	XXX
EBIT Margin	17%	XXX	14%	XXX	XXX	XXX
Net Profit	$231M	XXX	$168M	XXX	XXX	XXX
Net Margin	11%	XXX	9%	XXX	XXX	XXX
Net Debt	XXX	XXX	$936M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for ALS including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $2.1B. EBITDA for the last twelve months was $518M. In the most recent fiscal year, ALS achieved $2.0B in revenue and $444M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$2.1B	Analyst estimates available to subscribers	$2.0B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$1.8B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	89.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$518M	Analyst estimates available to subscribers	$444M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	24.5% EBITDA margin	Analyst estimates available to subscribers	22.5% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$370M	Analyst estimates available to subscribers	$279M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	17.5% EBIT margin	Analyst estimates available to subscribers	14.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$231M	Analyst estimates available to subscribers	$168M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	10.9% net profit margin	Analyst estimates available to subscribers	8.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$936M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for ALS

This financial data table provides comprehensive performance metrics for ALS, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

ALS generated $2.1B in revenue over the last twelve months.
The company achieved $518M in EBITDA over the last twelve months.
Net income over the last twelve months reached $231M.

Fiscal Year Performance

In the most recent fiscal year, ALS reported $2.0B in total revenue.
Fiscal year EBITDA was $444M.
The company maintained a gross profit margin of 89.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 22.5%.
Net profit margin reached 8.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for ALS. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

ALS Stock Performance

ALS has current market cap of AUD 11.1B (or $7.3B), and EV of AUD 12.6B (or $8.3B).

Market Cap Evolution

ALS Stock Data

As of December 5, 2025, ALS's stock price is AUD 22 (or $14).

See ALS trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$8.3B	$7.3B	XXX	XXX	XXX	XXX	$0.47

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

ALS Valuation Multiples

ALS's trades at 4.4x EV/Revenue multiple, and 21.2x EV/EBITDA.

See valuation multiples for ALS and 15K+ public comps

ALS Financial Valuation Multiples

As of December 5, 2025, ALS has market cap of $7.3B and EV of $8.3B.

Equity research analysts estimate ALS's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

ALS has a P/E ratio of 31.5x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$7.3B	XXX	$7.3B	XXX	XXX	XXX
EV (current)	$8.3B	XXX	$8.3B	XXX	XXX	XXX
EV/Revenue	3.9x	XXX	4.4x	XXX	XXX	XXX
EV/EBITDA	16.0x	XXX	21.2x	XXX	XXX	XXX
EV/EBIT	22.4x	XXX	30.1x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	31.5x	XXX	56.6x	XXX	XXX	XXX
EV/FCF	52.1x	XXX	54.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get ALS Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

ALS Margins & Growth Rates

ALS's last 12 month revenue growth is 9%

ALS's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

ALS's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

ALS's rule of X is 47% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for ALS and other 15K+ public comps

ALS Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	9%	XXX	11%	XXX	XXX	XXX
EBITDA Margin	24%	XXX	21%	XXX	XXX	XXX
EBITDA Growth	12%	XXX	22%	XXX	XXX	XXX
Rule of 40	30%	XXX	30%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	47%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	76%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial

ALS Public Comps

See public comps and valuation multiples for Laboratory Services comps

	EV/Revenue			EV/EBITDA
	2025E	2026E	2027E	2025E	2026E	2027E
Australian Clinical Labs	XXX	XXX	XXX	XXX	XXX	XXX
Healius	XXX	XXX	XXX	XXX	XXX	XXX
Integral Diagnostics	XXX	XXX	XXX	XXX	XXX	XXX
Sonic Healthcare	XXX	XXX	XXX	XXX	XXX	XXX
Bangkok Dusit Medical Services	XXX	XXX	XXX	XXX	XXX	XXX
XXXXXXXX	XXX	XXX	XXX	XXX	XXX	XXX
XXXXXXXX	XXX	XXX	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc.

ALS M&A and Investment Activity

ALS acquired XXX companies to date.

Last acquisition by ALS was XXXXXXXX, XXXXX XXXXX XXXXXX . ALS acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).

See M&A valuation multiples

Latest Acquisitions by ALS

Acquired Company	EV	EV/Revenue	EV/EBITDA
XXXXXXXXX	XXX	XXX	XXX
XXXXXXXXX	XXX	XXX	XXX
XXXXXXXXX	XXX	XXX	XXX
XXXXXXXXX	XXX	XXX	XXX
XXXXXXXXX	XXX	XXX	XXX

Get Verified M&A Valuation Multiples

Start Free Trial

About ALS

When was ALS founded?	ALS was founded in 1910.
Where is ALS headquartered?	ALS is headquartered in Australia.
How many employees does ALS have?	As of today, ALS has 20.5K+ employees.
Who is the CEO of ALS?	ALS's CEO is Mr. Malcolm Deane.
Is ALS publicy listed?	Yes, ALS is a public company listed on ASX.
What is the stock symbol of ALS?	ALS trades under ALQ ticker.
When did ALS go public?	ALS went public in 1952.
Who are competitors of ALS?	Similar companies to ALS include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare.
What is the current market cap of ALS?	ALS's current market cap is $7.3B
What is the current revenue of ALS?	ALS's last 12 months revenue is $2.1B.
What is the current revenue growth of ALS?	ALS revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of ALS?	Current revenue multiple of ALS is 3.9x.
Is ALS profitable?	Yes, ALS is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of ALS?	ALS's last 12 months EBITDA is $518M.
What is ALS's EBITDA margin?	ALS's last 12 months EBITDA margin is 24%.
What is the current EV/EBITDA multiple of ALS?	Current EBITDA multiple of ALS is 16.0x.
What is the current FCF of ALS?	ALS's last 12 months FCF is $159M.
What is ALS's FCF margin?	ALS's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of ALS?	Current FCF multiple of ALS is 52.1x.

ALS Valuation Multiples

Discover revenue and EBITDA valuation multiples for ALS and similar public comparables like Sonic Healthcare, Integral Diagnostics, and Australian Clinical Labs.

ALS Overview

About ALS

Founded

HQ

Employees

Website

Sectors

Financials

EV

Valuation Multiples

Valuation Multiples for 15K+ Public Comps

ALS Financials

ALS P&L

Financial Performance Summary for ALS

Recent Performance Highlights

Fiscal Year Performance

ALS Stock Performance

Market Cap Evolution

ALS Stock Data

Benchmark Trading Valuation Multiples by Industry

ALS Valuation Multiples

EV/Revenue (LTM) Evolution

ALS Financial Valuation Multiples

Get ALS Valuation Multiples

ALS Margins & Growth Rates

ALS Operational Valuation Multiples

Valuation Multiples Across 220+ Verticals

ALS Public Comps

ALS M&A and Investment Activity

Latest Acquisitions by ALS

Get Verified M&A Valuation Multiples

About ALS

Join Now Or Talk To Us

Join Our Newsletter